|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/7072 | |
| A61K 31/4188 | |||
| A61K 9/16 | |||
| A61K 9/20 |
| (11) | Patento numeris | 3038601 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14704501.7 |
| Europos patento paraiškos padavimo data | 2014-01-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/013930 |
| Data | 2014-01-30 |
| (87) | Numeris | WO 2015/030853 |
| Data | 2015-03-05 |
| (30) | Numeris | Data | Šalis |
| 201361870712 P | 2013-08-27 | US | |
| 201361898690 P | 2013-11-01 | US | |
| 201361907308 P | 2013-11-21 | US |
| (72) |
GORMAN, Eric, US
MOGALIAN, Erik, US
OLIYAI, Reza, US
STEFANIDIS, Dimitrios, US
WISER, Lauren, US
ZIA, Vahid, US
|
| (73) |
Gilead Pharmasset LLC,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS |
| COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS |